StockWatch
·
Services-Medical Laboratories
AcquisitionsAug 13, 2026, 05:33 PM

Freenome Amends 8-K with Q2 2026 Financials Post-Acquisition

AI Summary

Freenome, Inc. (formerly Perceptive Capital Solutions Corp.) filed an amendment to its 8-K report to include unaudited condensed consolidated financial statements for Freenome Holdings, Inc. and unaudited pro forma condensed combined financial information following the business combination consummated on July 20, 2026. The financial statements for Freenome Holdings, Inc. show a net loss of $69.0 million for the second quarter of 2026 and total revenue of $2.3 million for the same period. The company reported an accumulated deficit of $1.5 billion as of June 30, 2026, but stated that the $295.5 million net proceeds from the business combination are expected to fund operations for at least the next 12 months.

Key Highlights

  • Freenome reported a net loss of $69.0 million for the three months ended June 30, 2026.
  • Freenome's total revenue for Q2 2026 was $2.3 million, up from $1.1 million in Q2 2025.
  • Research and development expenses for Freenome were $54.3 million in Q2 2026.
  • As of June 30, 2026, Freenome had $102.0 million in cash, cash equivalents, and short-term marketable securities.
  • The business combination with PCSC provided net proceeds of $295.5 million.
  • Freenome's accumulated deficit reached $1.5 billion as of June 30, 2026.